NewsRx

Search our medical news database

Personnel

Company focusing on osteoporosis adds member to board

Published in Women's Health Weekly, August 25th, 2005

Osteologix Inc. announced the appointment of Bobby W. Sandage, Jr., PhD to the company's board of directors.

Sandage is executive vice president, research and development and chief scientific officer of Indevus Pharmaceuticals, Inc.

Sandage previously held senior development positions with DuPont Merck Pharmaceutical Company and was affiliated with the Medical Department of DuPont Critical Care, most recently as associate medical director. Sandage is an adjunct professor in the department of pharmacology at the Massachusetts College of Pharmacy. He received his PhD in clinical pharmacy from Purdue University and his BS in pharmacy from the University...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook